Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Deferred Revenue (2020 - 2021)

BioAtla's Current Deferred Revenue history spans 2 years, with the latest figure at $482000.0 for Q3 2021.

  • For Q3 2021, Current Deferred Revenue changed N/A year-over-year to $482000.0; the TTM value through Sep 2021 reached $482000.0, changed N/A, while the annual FY2020 figure was $387000.0, N/A changed from the prior year.
  • Current Deferred Revenue reached $482000.0 in Q3 2021 per BCAB's latest filing, down from $19.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $19.8 million in Q1 2021 to a low of $387000.0 in Q4 2020.